To continue to assess the clinical efficacy and safety of Certolizumab as add-on therapy with stable-dose DMARDs
Read more: http://www.clinicaltrials.gov/ct2/show/NCT00843778?cond=%22Arthritis%22&lup_s=07/28/2011&lup_d=30
Maintenance notice: Some features that submit or update information are temporarily disabled while we migrate the website. You can continue browsing normally. Thank you for your understanding.
To continue to assess the clinical efficacy and safety of Certolizumab as add-on therapy with stable-dose DMARDs
Read more: http://www.clinicaltrials.gov/ct2/show/NCT00843778?cond=%22Arthritis%22&lup_s=07/28/2011&lup_d=30
Improving orthopaedic care, education and research using Internet technologies